Virtual Presentation

Allogeneic Transplantation for Ph+ Acute Lymphoblastic Leukemia

Source: Current Treatment Options in Acute Lymphoblastic Leukemia

Allogeneic Transplantation for Ph+ Acute Lymphoblastic Leukemia

Program Director: Martin S. Tallman, MD

Faculty:

Jacob M. Rowe, MD, FACP

CREDIT INFORMATION

Release Date: April 30, 2009

Expiration Date: April 29, 2010

Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe current treatment approaches in Philadelphia chromosome–positive acute lymphoblastic leukemia
Compare results of recent clinical studies evaluating the role of allogeneic transplantation in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia
Contrast reduced-intensity conditioning regimens used before allogeneic transplantation in patients with acute lymphoblastic leukemia
Identify treatment options for acute lymphoblastic leukemia that is resistant to or refractory to imatinib

CCO Virtual Presentations combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.